Healthpeak Properties, Inc. (NYSE:DOC) Shares Sold by Bessemer Group Inc.

Bessemer Group Inc. cut its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 67.0% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 45,783 shares of the real estate investment trust's stock after selling 93,066 shares during the period. Bessemer Group Inc.'s holdings in Healthpeak Properties were worth $925,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Mizuho Bank Ltd. acquired a new stake in Healthpeak Properties during the 4th quarter worth about $28,000. Harvest Fund Management Co. Ltd acquired a new stake in Healthpeak Properties in the fourth quarter valued at approximately $30,000. Future Financial Wealth Managment LLC acquired a new position in shares of Healthpeak Properties during the 1st quarter worth approximately $30,000. S.A. Mason LLC raised its stake in shares of Healthpeak Properties by 160.9% during the 1st quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock worth $30,000 after buying an additional 925 shares during the period. Finally, Covestor Ltd lifted its position in shares of Healthpeak Properties by 173.8% during the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust's stock valued at $37,000 after buying an additional 1,152 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company's stock.

Healthpeak Properties Stock Performance

Shares of Healthpeak Properties stock traded down $0.07 during trading hours on Friday, hitting $18.25. 5,546,828 shares of the company were exchanged, compared to its average volume of 5,320,639. The business has a 50-day moving average of $17.42 and a 200-day moving average of $19.03. Healthpeak Properties, Inc. has a 1 year low of $16.64 and a 1 year high of $23.26. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.01. The stock has a market capitalization of $12.68 billion, a price-to-earnings ratio of 45.61, a P/E/G ratio of 2.08 and a beta of 1.03.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The real estate investment trust reported $0.46 EPS for the quarter, hitting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 9.99% and a return on equity of 3.06%. The company had revenue of $702.89 million during the quarter, compared to the consensus estimate of $690.76 million. During the same quarter in the prior year, the firm earned $0.45 EPS. Healthpeak Properties's quarterly revenue was up 15.9% on a year-over-year basis. As a group, analysts expect that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The company also recently disclosed a dividend, which was paid on Friday, May 30th. Investors of record on Tuesday, May 20th were given a $0.1017 dividend. The ex-dividend date was Monday, May 19th. This represents a yield of 7.05%. Healthpeak Properties's payout ratio is currently 305.00%.

Insider Buying and Selling at Healthpeak Properties

In other Healthpeak Properties news, Director Tommy G. Thompson bought 5,777 shares of the business's stock in a transaction dated Wednesday, May 28th. The stock was acquired at an average cost of $17.27 per share, with a total value of $99,768.79. Following the purchase, the director owned 144,290 shares in the company, valued at approximately $2,491,888.30. This represents a 4.17% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director John T. Thomas purchased 4,200 shares of the firm's stock in a transaction that occurred on Monday, April 28th. The stock was acquired at an average price of $17.84 per share, for a total transaction of $74,928.00. Following the completion of the purchase, the director owned 813,566 shares of the company's stock, valued at approximately $14,514,017.44. This represents a 0.52% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 29,764 shares of company stock valued at $521,909. 0.23% of the stock is owned by corporate insiders.

Analyst Ratings Changes

DOC has been the topic of several research reports. Scotiabank decreased their target price on Healthpeak Properties from $23.00 to $21.00 and set a "sector outperform" rating on the stock in a research report on Monday, May 12th. Wells Fargo & Company cut their price objective on Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research report on Monday, June 2nd. Wedbush reduced their price objective on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a report on Monday, April 28th. Evercore ISI lowered their target price on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Finally, Argus reissued a "buy" rating and issued a $25.00 price target on shares of Healthpeak Properties in a research note on Tuesday, April 29th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $23.27.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.